APA (7th ed.) Citation

Mandavkar, A. A., Padakanti, S. S. N., Gupta, S., Akram, S., Jaffar, N., Chauhan, J., . . . Beniwal, S. S. (2025). Emerging therapies in Multiple Myeloma: Leveraging immune checkpoint inhibitors for improved outcomes. Human Antibodies, 33(1/2), 10. https://doi.org/10.1177/10932607241301699

Chicago Style (17th ed.) Citation

Mandavkar, Anuja Anil, et al. "Emerging Therapies in Multiple Myeloma: Leveraging Immune Checkpoint Inhibitors for Improved Outcomes." Human Antibodies 33, no. 1/2 (2025): 10. https://doi.org/10.1177/10932607241301699.

MLA (9th ed.) Citation

Mandavkar, Anuja Anil, et al. "Emerging Therapies in Multiple Myeloma: Leveraging Immune Checkpoint Inhibitors for Improved Outcomes." Human Antibodies, vol. 33, no. 1/2, 2025, p. 10, https://doi.org/10.1177/10932607241301699.